The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Alpha-Fetoprotein (AFP) Biomarker Market Research Report 2025
Synopsis
Hepatocellular carcinoma (HCC) is the seventh most common cancer diagnosis worldwide with high associated mortality. HCC is a unique malignancy, as it typically arises in the setting of chronic liver disease in particular cirrhosis, with competing risks of liver failure, contributing to its low 5-year survival rates of 18%–20%. More than half of worldwide HCC-related deaths occur in Asia, due to endemic hepatitis B (HBV) infection. HCC incidence is rising in many Western countries due to the rising prevalence of nonalcoholic fatty liver disease, alcohol-related liver disease, and hepatitis C (HCV)-related complications despite the availability of direct acting antiviral therapies. The search for biomarkers in hepatocellular carcinoma continues despite recent approvals for immune checkpoint inhibitor combinations, tyrosine kinase inhibitors [TKIs], and antiangiogenesic agents. Biomarkers can be either predictive or prognostic and the only biomarker that has been used clinically is the prognostic biomarker α-fetoprotein (AFP).
The global Alpha-Fetoprotein (AFP) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Alpha-Fetoprotein (AFP) Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Alpha-Fetoprotein (AFP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam and Bio-Techne, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alpha-Fetoprotein (AFP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-Fetoprotein (AFP) Biomarker.
Report Scope
The Alpha-Fetoprotein (AFP) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alpha-Fetoprotein (AFP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-Fetoprotein (AFP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
Labcorp
Thermo Fisher Scientific
Abcam
Bio-Techne
MyBiosource
RayBiotech
CUSABIO
Elabscience Biotechnology
Abbexa
Segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha-Fetoprotein (AFP) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Hepatocellular carcinoma (HCC) is the seventh most common cancer diagnosis worldwide with high associated mortality. HCC is a unique malignancy, as it typically arises in the setting of chronic liver disease in particular cirrhosis, with competing risks of liver failure, contributing to its low 5-year survival rates of 18%–20%. More than half of worldwide HCC-related deaths occur in Asia, due to endemic hepatitis B (HBV) infection. HCC incidence is rising in many Western countries due to the rising prevalence of nonalcoholic fatty liver disease, alcohol-related liver disease, and hepatitis C (HCV)-related complications despite the availability of direct acting antiviral therapies. The search for biomarkers in hepatocellular carcinoma continues despite recent approvals for immune checkpoint inhibitor combinations, tyrosine kinase inhibitors [TKIs], and antiangiogenesic agents. Biomarkers can be either predictive or prognostic and the only biomarker that has been used clinically is the prognostic biomarker α-fetoprotein (AFP).
The global Alpha-Fetoprotein (AFP) Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Alpha-Fetoprotein (AFP) Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Alpha-Fetoprotein (AFP) Biomarker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Alpha-Fetoprotein (AFP) Biomarker include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, Abcam and Bio-Techne, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Alpha-Fetoprotein (AFP) Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha-Fetoprotein (AFP) Biomarker.
Report Scope
The Alpha-Fetoprotein (AFP) Biomarker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alpha-Fetoprotein (AFP) Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha-Fetoprotein (AFP) Biomarker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
FUJIFILM
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
Labcorp
Thermo Fisher Scientific
Abcam
Bio-Techne
MyBiosource
RayBiotech
CUSABIO
Elabscience Biotechnology
Abbexa
Segment by Type
Liver Cancer
Testes Cancer
Ovarian Cancer
Others
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alpha-Fetoprotein (AFP) Biomarker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liver Cancer
1.2.3 Testes Cancer
1.2.4 Ovarian Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Perspective (2019-2030)
2.2 Alpha-Fetoprotein (AFP) Biomarker Growth Trends by Region
2.2.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Alpha-Fetoprotein (AFP) Biomarker Market Dynamics
2.3.1 Alpha-Fetoprotein (AFP) Biomarker Industry Trends
2.3.2 Alpha-Fetoprotein (AFP) Biomarker Market Drivers
2.3.3 Alpha-Fetoprotein (AFP) Biomarker Market Challenges
2.3.4 Alpha-Fetoprotein (AFP) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Revenue
3.1.1 Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Revenue (2019-2024)
3.1.2 Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alpha-Fetoprotein (AFP) Biomarker Revenue
3.4 Global Alpha-Fetoprotein (AFP) Biomarker Market Concentration Ratio
3.4.1 Global Alpha-Fetoprotein (AFP) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alpha-Fetoprotein (AFP) Biomarker Revenue in 2023
3.5 Alpha-Fetoprotein (AFP) Biomarker Key Players Head office and Area Served
3.6 Key Players Alpha-Fetoprotein (AFP) Biomarker Product Solution and Service
3.7 Date of Enter into Alpha-Fetoprotein (AFP) Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alpha-Fetoprotein (AFP) Biomarker Breakdown Data by Type
4.1 Global Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Type (2025-2030)
5 Alpha-Fetoprotein (AFP) Biomarker Breakdown Data by Application
5.1 Global Alpha-Fetoprotein (AFP) Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)
6.2 North America Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)
6.4 North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)
7.2 Europe Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)
7.4 Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)
9.2 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)
9.4 Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 FUJIFILM
11.1.1 FUJIFILM Company Detail
11.1.2 FUJIFILM Business Overview
11.1.3 FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Introduction
11.1.4 FUJIFILM Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.1.5 FUJIFILM Recent Development
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Detail
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Introduction
11.2.4 Eli Lilly and Company Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.2.5 Eli Lilly and Company Recent Development
11.3 Fujirebio
11.3.1 Fujirebio Company Detail
11.3.2 Fujirebio Business Overview
11.3.3 Fujirebio Alpha-Fetoprotein (AFP) Biomarker Introduction
11.3.4 Fujirebio Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.3.5 Fujirebio Recent Development
11.4 Roche Diagnostics
11.4.1 Roche Diagnostics Company Detail
11.4.2 Roche Diagnostics Business Overview
11.4.3 Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Introduction
11.4.4 Roche Diagnostics Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.4.5 Roche Diagnostics Recent Development
11.5 Fapon Biotech
11.5.1 Fapon Biotech Company Detail
11.5.2 Fapon Biotech Business Overview
11.5.3 Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Introduction
11.5.4 Fapon Biotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.5.5 Fapon Biotech Recent Development
11.6 Labcorp
11.6.1 Labcorp Company Detail
11.6.2 Labcorp Business Overview
11.6.3 Labcorp Alpha-Fetoprotein (AFP) Biomarker Introduction
11.6.4 Labcorp Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.6.5 Labcorp Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Introduction
11.7.4 Thermo Fisher Scientific Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Abcam
11.8.1 Abcam Company Detail
11.8.2 Abcam Business Overview
11.8.3 Abcam Alpha-Fetoprotein (AFP) Biomarker Introduction
11.8.4 Abcam Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.8.5 Abcam Recent Development
11.9 Bio-Techne
11.9.1 Bio-Techne Company Detail
11.9.2 Bio-Techne Business Overview
11.9.3 Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Introduction
11.9.4 Bio-Techne Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.9.5 Bio-Techne Recent Development
11.10 MyBiosource
11.10.1 MyBiosource Company Detail
11.10.2 MyBiosource Business Overview
11.10.3 MyBiosource Alpha-Fetoprotein (AFP) Biomarker Introduction
11.10.4 MyBiosource Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.10.5 MyBiosource Recent Development
11.11 RayBiotech
11.11.1 RayBiotech Company Detail
11.11.2 RayBiotech Business Overview
11.11.3 RayBiotech Alpha-Fetoprotein (AFP) Biomarker Introduction
11.11.4 RayBiotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.11.5 RayBiotech Recent Development
11.12 CUSABIO
11.12.1 CUSABIO Company Detail
11.12.2 CUSABIO Business Overview
11.12.3 CUSABIO Alpha-Fetoprotein (AFP) Biomarker Introduction
11.12.4 CUSABIO Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.12.5 CUSABIO Recent Development
11.13 Elabscience Biotechnology
11.13.1 Elabscience Biotechnology Company Detail
11.13.2 Elabscience Biotechnology Business Overview
11.13.3 Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Introduction
11.13.4 Elabscience Biotechnology Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.13.5 Elabscience Biotechnology Recent Development
11.14 Abbexa
11.14.1 Abbexa Company Detail
11.14.2 Abbexa Business Overview
11.14.3 Abbexa Alpha-Fetoprotein (AFP) Biomarker Introduction
11.14.4 Abbexa Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
11.14.5 Abbexa Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liver Cancer
Table 3. Key Players of Testes Cancer
Table 4. Key Players of Ovarian Cancer
Table 5. Key Players of Others
Table 6. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2019-2024)
Table 10. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2025-2030)
Table 12. Alpha-Fetoprotein (AFP) Biomarker Market Trends
Table 13. Alpha-Fetoprotein (AFP) Biomarker Market Drivers
Table 14. Alpha-Fetoprotein (AFP) Biomarker Market Challenges
Table 15. Alpha-Fetoprotein (AFP) Biomarker Market Restraints
Table 16. Global Alpha-Fetoprotein (AFP) Biomarker Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Players (2019-2024)
Table 18. Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-Fetoprotein (AFP) Biomarker as of 2023)
Table 19. Ranking of Global Top Alpha-Fetoprotein (AFP) Biomarker Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Alpha-Fetoprotein (AFP) Biomarker Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alpha-Fetoprotein (AFP) Biomarker Product Solution and Service
Table 23. Date of Enter into Alpha-Fetoprotein (AFP) Biomarker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Type (2019-2024)
Table 27. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Type (2025-2030)
Table 29. Global Alpha-Fetoprotein (AFP) Biomarker Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Application (2019-2024)
Table 31. Global Alpha-Fetoprotein (AFP) Biomarker Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Alpha-Fetoprotein (AFP) Biomarker Revenue Market Share by Application (2025-2030)
Table 33. North America Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size by Country (2025-2030) & (US$ Million)
Table 48. FUJIFILM Company Detail
Table 49. FUJIFILM Business Overview
Table 50. FUJIFILM Alpha-Fetoprotein (AFP) Biomarker Product
Table 51. FUJIFILM Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 52. FUJIFILM Recent Development
Table 53. Eli Lilly and Company Company Detail
Table 54. Eli Lilly and Company Business Overview
Table 55. Eli Lilly and Company Alpha-Fetoprotein (AFP) Biomarker Product
Table 56. Eli Lilly and Company Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 57. Eli Lilly and Company Recent Development
Table 58. Fujirebio Company Detail
Table 59. Fujirebio Business Overview
Table 60. Fujirebio Alpha-Fetoprotein (AFP) Biomarker Product
Table 61. Fujirebio Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 62. Fujirebio Recent Development
Table 63. Roche Diagnostics Company Detail
Table 64. Roche Diagnostics Business Overview
Table 65. Roche Diagnostics Alpha-Fetoprotein (AFP) Biomarker Product
Table 66. Roche Diagnostics Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 67. Roche Diagnostics Recent Development
Table 68. Fapon Biotech Company Detail
Table 69. Fapon Biotech Business Overview
Table 70. Fapon Biotech Alpha-Fetoprotein (AFP) Biomarker Product
Table 71. Fapon Biotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 72. Fapon Biotech Recent Development
Table 73. Labcorp Company Detail
Table 74. Labcorp Business Overview
Table 75. Labcorp Alpha-Fetoprotein (AFP) Biomarker Product
Table 76. Labcorp Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 77. Labcorp Recent Development
Table 78. Thermo Fisher Scientific Company Detail
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Alpha-Fetoprotein (AFP) Biomarker Product
Table 81. Thermo Fisher Scientific Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Development
Table 83. Abcam Company Detail
Table 84. Abcam Business Overview
Table 85. Abcam Alpha-Fetoprotein (AFP) Biomarker Product
Table 86. Abcam Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 87. Abcam Recent Development
Table 88. Bio-Techne Company Detail
Table 89. Bio-Techne Business Overview
Table 90. Bio-Techne Alpha-Fetoprotein (AFP) Biomarker Product
Table 91. Bio-Techne Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 92. Bio-Techne Recent Development
Table 93. MyBiosource Company Detail
Table 94. MyBiosource Business Overview
Table 95. MyBiosource Alpha-Fetoprotein (AFP) Biomarker Product
Table 96. MyBiosource Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 97. MyBiosource Recent Development
Table 98. RayBiotech Company Detail
Table 99. RayBiotech Business Overview
Table 100. RayBiotech Alpha-Fetoprotein (AFP) Biomarker Product
Table 101. RayBiotech Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 102. RayBiotech Recent Development
Table 103. CUSABIO Company Detail
Table 104. CUSABIO Business Overview
Table 105. CUSABIO Alpha-Fetoprotein (AFP) Biomarker Product
Table 106. CUSABIO Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 107. CUSABIO Recent Development
Table 108. Elabscience Biotechnology Company Detail
Table 109. Elabscience Biotechnology Business Overview
Table 110. Elabscience Biotechnology Alpha-Fetoprotein (AFP) Biomarker Product
Table 111. Elabscience Biotechnology Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 112. Elabscience Biotechnology Recent Development
Table 113. Abbexa Company Detail
Table 114. Abbexa Business Overview
Table 115. Abbexa Alpha-Fetoprotein (AFP) Biomarker Product
Table 116. Abbexa Revenue in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024) & (US$ Million)
Table 117. Abbexa Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Type: 2023 VS 2030
Figure 3. Liver Cancer Features
Figure 4. Testes Cancer Features
Figure 5. Ovarian Cancer Features
Figure 6. Others Features
Figure 7. Global Alpha-Fetoprotein (AFP) Biomarker Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Alpha-Fetoprotein (AFP) Biomarker Report Years Considered
Figure 13. Global Alpha-Fetoprotein (AFP) Biomarker Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Alpha-Fetoprotein (AFP) Biomarker Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Region: 2023 VS 2030
Figure 16. Global Alpha-Fetoprotein (AFP) Biomarker Market Share by Players in 2023
Figure 17. Global Top Alpha-Fetoprotein (AFP) Biomarker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha-Fetoprotein (AFP) Biomarker as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Alpha-Fetoprotein (AFP) Biomarker Revenue in 2023
Figure 19. North America Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)
Figure 21. United States Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)
Figure 25. Germany Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Alpha-Fetoprotein (AFP) Biomarker Market Share by Region (2019-2030)
Figure 33. China Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)
Figure 41. Mexico Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Alpha-Fetoprotein (AFP) Biomarker Market Share by Country (2019-2030)
Figure 45. Turkey Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Alpha-Fetoprotein (AFP) Biomarker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. FUJIFILM Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 48. Eli Lilly and Company Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 49. Fujirebio Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 50. Roche Diagnostics Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 51. Fapon Biotech Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 52. Labcorp Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 53. Thermo Fisher Scientific Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 54. Abcam Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 55. Bio-Techne Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 56. MyBiosource Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 57. RayBiotech Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 58. CUSABIO Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 59. Elabscience Biotechnology Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 60. Abbexa Revenue Growth Rate in Alpha-Fetoprotein (AFP) Biomarker Business (2019-2024)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
